GENE ONLINE|News &
Opinion
Blog

Cancer Vaccine
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
Moderna’s Cancer Vaccine to Enter Phase 3 Trials This Year
2023-04-17
Moderna’s Personalized Cancer Therapy: The New Transformative Approach to Oncology
2022-12-08
Senescent Cancer Cells Vaccine Boost Immune Response
2022-11-07
Amazon, Fred Hutchinson Begin Human Trial for Cancer Vaccine
2022-07-14
This One-Time Injection Could Cure AIDS
2022-06-21
Vaccines Against Cancers May Be the Future
2022-05-30
In a Blockbuster Day, Vaccibody Gets New Name and a Multi-Program Regeneron Deal to Boot
2021-11-24
Moderna’s mRNA-Based Cancer Vaccine Shows Encouraging Results in Phase 1 Trial
2020-11-13
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top